Hartaj Singh Score: 14
Analyst at
Oppenheimer
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-29.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
38%
6 W / 10 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
17%
2 W / 10 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 12 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
43%
6 W / 8 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
33%
5 W / 10 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 05, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$540.00
Est. +8%
|
$499.10 | $519.88 |
Miss
|
$450.69
-9.7%
|
| Aug 28, 2024 |
United Therapeutics Corp
UTHR
|
BUY |
$575.00
Est. +59%
|
$362.45 | $417.82 |
Miss
|
$549.57
+51.6%
|
| Aug 05, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$550.00
Est. +15%
|
$477.86 | $519.88 |
Miss
|
$450.69
-5.7%
|
| Jun 12, 2024 |
Moderna Inc
MRNA
|
BUY |
$179.00
Est. +21%
|
$148.39 | $129.36 |
Miss
|
$52.13
-64.9%
|
| May 21, 2024 |
Astria Therapeutics Inc
ATXS
|
BUY |
$25.00
Est. +161%
|
$9.59 | $12.92 |
Miss
|
$12.58
+31.2%
|
| May 14, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$180.00
Est. +37%
|
$131.70 | $155.95 |
Miss
|
$15.77
-88.0%
|
| May 14, 2024 |
Inovio Pharmaceuticals Inc
INO
|
BUY |
$40.00
Est. +249%
|
$11.45 | $12.33 |
Miss
|
$1.10
-90.4%
|
| May 03, 2024 |
Moderna Inc
MRNA
|
BUY |
$163.00
Est. +30%
|
$125.59 | $129.36 |
Miss
|
$52.13
-58.5%
|
| May 02, 2024 |
United Therapeutics Corp
UTHR
|
BUY |
$400.00
Est. +57%
|
$255.14 | $417.82 |
Target Met
|
$549.57
+115.4%
|
| Mar 26, 2024 |
Astria Therapeutics Inc
ATXS
|
BUY |
$29.00
Est. +105%
|
$14.12 | $12.92 |
Miss
|
$12.58
-10.9%
|
| Jan 25, 2024 |
Inovio Pharmaceuticals Inc
INO
|
SELL |
$4.00
Est. +41%
|
$6.79 | $1.75 (Low) |
Target Met
|
$1.10
+83.8%
|
| Jan 02, 2024 |
Moderna Inc
MRNA
|
BUY |
$142.00
Est. +25%
|
$113.15 | $129.36 |
Miss
|
$52.13
-53.9%
|
| Aug 15, 2022 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$150.00
Est. +38%
|
$109.00 | - | - |
$15.77
-85.5%
|
| Apr 06, 2022 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$350.00
Est. +28%
|
$272.39 | - | - |
$450.69
+65.5%
|
| Feb 03, 2022 |
Gilead Sciences, Inc.
GILD
|
BUY |
$90.00
Est. +39%
|
$64.57 | - | - |
$124.30
+92.5%
|
| Jan 04, 2022 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$125.00
Est. +40%
|
$89.16 | - | - |
$15.77
-82.3%
|
Vertex Pharmaceuticals, Inc.
VRTX
Nov 05, 2024
Signal & Target
BUY
$540.00
Start Price
$499.10
Best Price (1Y)
$519.88
Current Price
$450.69
Return
-9.7%
United Therapeutics Corp
UTHR
Aug 28, 2024
Signal & Target
BUY
$575.00
Start Price
$362.45
Best Price (1Y)
$417.82
Current Price
$549.57
Return
+51.6%
Vertex Pharmaceuticals, Inc.
VRTX
Aug 05, 2024
Signal & Target
BUY
$550.00
Start Price
$477.86
Best Price (1Y)
$519.88
Current Price
$450.69
Return
-5.7%
Moderna Inc
MRNA
Jun 12, 2024
Signal & Target
BUY
$179.00
Start Price
$148.39
Best Price (1Y)
$129.36
Current Price
$52.13
Return
-64.9%
Astria Therapeutics Inc
ATXS
May 21, 2024
Signal & Target
BUY
$25.00
Start Price
$9.59
Best Price (1Y)
$12.92
Current Price
$12.58
Return
+31.2%
Sarepta Therapeutics Inc
SRPT
May 14, 2024
Signal & Target
BUY
$180.00
Start Price
$131.70
Best Price (1Y)
$155.95
Current Price
$15.77
Return
-88.0%
Inovio Pharmaceuticals Inc
INO
May 14, 2024
Signal & Target
BUY
$40.00
Start Price
$11.45
Best Price (1Y)
$12.33
Current Price
$1.10
Return
-90.4%
Moderna Inc
MRNA
May 03, 2024
Signal & Target
BUY
$163.00
Start Price
$125.59
Best Price (1Y)
$129.36
Current Price
$52.13
Return
-58.5%
United Therapeutics Corp
UTHR
May 02, 2024
Signal & Target
BUY
$400.00
Start Price
$255.14
Best Price (1Y)
$417.82
Current Price
$549.57
Return
+115.4%
Astria Therapeutics Inc
ATXS
Mar 26, 2024
Signal & Target
BUY
$29.00
Start Price
$14.12
Best Price (1Y)
$12.92
Current Price
$12.58
Return
-10.9%
Inovio Pharmaceuticals Inc
INO
Jan 25, 2024
Signal & Target
SELL
$4.00
Start Price
$6.79
Best Price (1Y)
$1.75
Current Price
$1.10
Return
+83.8%
Moderna Inc
MRNA
Jan 02, 2024
Signal & Target
BUY
$142.00
Start Price
$113.15
Best Price (1Y)
$129.36
Current Price
$52.13
Return
-53.9%
Sarepta Therapeutics Inc
SRPT
Aug 15, 2022
Signal & Target
BUY
$150.00
Start Price
$109.00
Best Price (1Y)
-
Current Price
$15.77
Return
-85.5%
Vertex Pharmaceuticals, Inc.
VRTX
Apr 06, 2022
Signal & Target
BUY
$350.00
Start Price
$272.39
Best Price (1Y)
-
Current Price
$450.69
Return
+65.5%
Gilead Sciences, Inc.
GILD
Feb 03, 2022
Signal & Target
BUY
$90.00
Start Price
$64.57
Best Price (1Y)
-
Current Price
$124.30
Return
+92.5%
Sarepta Therapeutics Inc
SRPT
Jan 04, 2022
Signal & Target
BUY
$125.00
Start Price
$89.16
Best Price (1Y)
-
Current Price
$15.77
Return
-82.3%